灵康药业：全资子公司注射用头孢唑肟钠拟中选第十一批全国药品集中采购

Core Viewpoint - Lingkang Pharmaceutical (603669) announced participation in the 11th batch of national centralized drug procurement organized by the National Organization for Drug Procurement Office, with its product, injectable Cefoperazone Sodium, expected to be selected for this procurement [1] Group 1 - Lingkang Pharmaceutical's wholly-owned subsidiary, Lingkang Pharmaceutical, is involved in the national drug centralized procurement process [1] - The National Organization for Drug Procurement Office has published the proposed selection results for the centralized procurement [1] - Injectable Cefoperazone Sodium from Lingkang Pharmaceutical is anticipated to be included in this procurement round [1]